Subchorionic Hematomas and Adverse Pregnancy Outcomes among Twin Pregnancies.


Journal

American journal of perinatology
ISSN: 1098-8785
Titre abrégé: Am J Perinatol
Pays: United States
ID NLM: 8405212

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 31 12 2019
medline: 15 12 2021
entrez: 31 12 2019
Statut: ppublish

Résumé

This study estimates the association of a first trimester finding of subchorionic hematoma (SCH) with third trimester adverse pregnancy outcomes in women with twin pregnancies. Retrospective cohort study of twin pregnancies prior to 14 weeks at a single institution from 2005 to 2019, all of whom had a first trimester ultrasound. We excluded monoamniotic twins, fetal anomalies, history of fetal reduction or spontaneous reduction, and twin-to-twin transfusion syndrome. Ultrasound data were reviewed, and we compared pregnancy outcomes after 24 weeks in women with and without a SCH at their initial ultrasound 6 A total of 760 women with twin pregnancies met inclusion criteria for the study, 68 (8.9%) of whom had a SCH. Women with SCH were more likely to have vaginal bleeding and had their initial ultrasound at earlier gestational ages. On univariate analysis, SCH was not significantly associated with gestational age at delivery, preterm birth, birthweight of either twin, low birthweight percentiles of either twin, fetal demise, or preeclampsia. SCH was associated with placental abruption on univariate analysis, but not after controlling for vaginal bleeding and gestational age at the time of the initial ultrasound (adjusted odds ratio: 2.00, 95% confidence interval: 0.63-6.42). Among women with SCH, SCH size was not associated with adverse pregnancy outcomes. In women with twin pregnancies, the finding of a first trimester SCH is not associated with adverse pregnancy outcomes >24 weeks.

Identifiants

pubmed: 31887747
doi: 10.1055/s-0039-3401852
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

779-783

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Mariam Naqvi (M)

Maternal Fetal Medicine Associates, PLLC, New York, New York.
Icahn School of Medicine at Mount Sinai, New York, New York.

Mackenzie N Naert (MN)

Icahn School of Medicine at Mount Sinai, New York, New York.

Hanaa Khadraoui (H)

Touro College of Osteopathic Medicine, Harlem, New York, New York.

Alberto M Rodriguez (AM)

Icahn School of Medicine at Mount Sinai, New York, New York.

Amalia G Namath (AG)

Georgetown University School of Medicine, Washington, District of Columbia.

Munira Ali (M)

Touro College of Osteopathic Medicine, Harlem, New York, New York.

Nathan S Fox (NS)

Maternal Fetal Medicine Associates, PLLC, New York, New York.
Icahn School of Medicine at Mount Sinai, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH